Back
Aptevo Therapeutics Stock Price Chart
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
1
APVO
Aptevo Therapeutics
Last Price:
0.18
Seasonality Move:
47.05%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APVO is experiencing slight buying pressure.
Aptevo Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.31 | Sell |
| 20-day SMA: | 0.34 | Sell |
| 50-day SMA: | 0.38 | Sell |
| 200-day SMA: | 3.2 | Sell |
| 8-day EMA: | 0.28 | Sell |
| 20-day EMA: | 0.33 | Sell |
| 50-day EMA: | 0.45 | Sell |
| 200-day EMA: | 8.63 | Sell |
Aptevo Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 20.92 | Sell |
| Chaikin Money Flow: | -740150 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.3 - 0.42) | Sell |
| Bollinger Bands (100): | (0.31 - 0.77) | Sell |
Aptevo Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aptevo Therapeutics Stock
Is Aptevo Therapeutics Stock a Buy?
- Aptevo Therapeutics share price is 0.17 while APVO 8-day simple moving average is 0.31, which is a Sell signal.
- The stock price of APVO is 0.17 while Aptevo Therapeutics 20-day SMA is 0.34, which makes it a Sell.
- Aptevo Therapeutics 50-day simple moving average is 0.38 while APVO share price is 0.17, making it a Sell technically.
- APVO stock price is 0.17 and Aptevo Therapeutics 200-day simple moving average is 3.20, creating a Sell signal.
APVO Technical Analysis vs Fundamental Analysis
Sell
1
Aptevo Therapeutics (APVO)
is a Sell
Is Aptevo Therapeutics a Buy or a Sell?
-
Aptevo Therapeutics stock is rated a Sell
The current Aptevo Therapeutics [APVO] share price is $0.17. The Score for APVO is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
Aptevo Therapeutics Stock Info
Market Cap:
1.56M
Price in USD:
0.17
Share Volume:
4.82M
Aptevo Therapeutics 52-Week Range
52-Week High:
21.56
52-Week Low:
0.14
Sell
1
Aptevo Therapeutics (APVO)
is a Sell
Aptevo Therapeutics Share Price Forecast
-
What is the Aptevo Therapeutics stock price today?
The Aptevo Therapeutics stock price is 0.17 USD today. -
Will APVO stock go up or go down?
Aptevo Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aptevo Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aptevo Therapeutics is overvalued.
Is Aptevo Therapeutics Stock a Buy?
- Aptevo Therapeutics share price is 0.17 while APVO 8-day exponential moving average is 0.28, which is a Sell signal.
- The stock price of APVO is 0.17 while Aptevo Therapeutics 20-day EMA is 0.33, which makes it a Sell.
- Aptevo Therapeutics 50-day exponential moving average is 0.45 while APVO share price is 0.17, making it a Sell technically.
- APVO stock price is 0.17 and Aptevo Therapeutics 200-day simple moving average is 8.63, creating a Sell signal.
Fundamental Analysis of Aptevo Therapeutics
Is Aptevo Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $32.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $93.60 per share, and an increase next year of $2.02 per share.
Technical Analysis of Aptevo Therapeutics
Should I short Aptevo Therapeutics stock?
- APVO Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Aptevo Therapeutics is a Sell
- Aptevo Therapeutics Relative Strength Index (RSI) is 20.92, which suggest Aptevo Therapeutics is oversold
- The Bollinger Bands (25) for Aptevo Therapeutics is (0.3 - 0.42), which suggest Aptevo Therapeutics is a Sell
- The Bollinger Bands (100) for Aptevo Therapeutics is (0.31 - 0.77), which suggest Aptevo Therapeutics is a Sell
* Aptevo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.